Cutler Group LP Pacira Bio Sciences, Inc. Call Options Transaction History

Cutler Group LP

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2021 Apr 26, 2021	SELL	$59.31 - $78.82 $474,480 - $630,560	-8,000 Closed	0 $0
Q4 2020 Jan 21, 2021	BUY	$50.47 - $66.26 $403,760 - $530,080	8,000 New	8,000 $14,000
Q3 2019 Oct 28, 2019	SELL	$35.66 - $44.99 $356,599 - $449,900	-10,000 Closed	0 $0
Q2 2019 Aug 09, 2019	SELL	$36.57 - $47.97 $493,695 - $647,595	-13,500 Reduced 57.45%	10,000 $11,000
Q4 2018 Feb 05, 2019	SELL	$41.31 - $52.16 $45,441 - $57,375	-1,100 Reduced 4.47%	23,500 $17,000
Q3 2018 Nov 07, 2018	BUY	$32.85 - $52.0 $808,110 - $1.28 Million	24,600 New	24,600 $99,000
Q2 2018 Aug 10, 2018	SELL	$27.5 - $39.8 $618,750 - $895,499	-22,500 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$29.98 - $46.35 $374,750 - $579,375	12,500 Added 125.0%	22,500 $2,000
Q4 2017 Jan 17, 2018	BUY	$31.85 - $46.95 $159,250 - $234,750	5,000 Added 100.0%	10,000 $29,000
Q3 2017 Oct 17, 2017	BUY	$35.7 - $39.5 $178,500 - $197,500	5,000	5,000 $7,000

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $946M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.